A Novel Class of Human ADAM8 Inhibitory Antibodies for Treatment of Triple-Negative Breast Cancer

New targeted treatments are urgently needed to improve triple-negative breast cancer (TNBC) patient survival. Previously, we identified the cell surface protein A Disintegrin And Metalloprotease 8 (ADAM8) as a driver of TNBC tumor growth and spread via its metalloproteinase and disintegrin (MP and D...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Nora D. Mineva (Auteur), Stefania Pianetti (Auteur), Sonia G. Das (Auteur), Srimathi Srinivasan (Auteur), Nicolas M. Billiald (Auteur), Gail E. Sonenshein (Auteur)
Formaat: Boek
Gepubliceerd in: MDPI AG, 2024-04-01T00:00:00Z.
Onderwerpen:
Online toegang:Connect to this object online.
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Internet

Connect to this object online.

3rd Floor Main Library

Exemplaargegevens van 3rd Floor Main Library
Plaatsingsnummer: A1234.567
Kopie 1 Beschikbaar